Evaluation of the prevalence of critical patient polyneuromiopathy in an intensive care unit
DOI:
https://doi.org/10.15448/1983-652X.2019.1.32043Keywords:
polyneuropathy, weaning from the respirator, intensive care, mechanical invasive ventilation.Abstract
Objective: To evaluate the prevalence of critical illness polyneuromyopathy (CIPNM), through the measure of muscle strength, correlating with time of mechanical ventilation (MV), weaning and length of hospital stay in an intensive care unit (ICU).
Materials and Methods: This was a prospective cross-sectional study, in which men and women older than 18 years participated. Evaluations were performed by trained researchers, during the pause of sedation and with the patient eligible for weaning. Peripheral muscle strength was assessed through the MRC (Medical Research Council) scale, and the palmar grip strength through the PDP (palm groove dynamometry) of the dominant hand. Quantitative variables were described by mean and standard deviation; and the categorical ones by absolute and relative frequencies. To verify correlations between data, a Spearman correlation test was performed with a statistical significance level of 5%.
Results: A total of 39 patients with a predominance of males (n=21, 53.8%), mean age of 63.67±17.61 were included. 66.7% (n=26) of patients fulfilled some criterion for the diagnosis of polyneuromiopathy. The prevalence of CIPNM, diagnosed by the MRC scale, was observed in 23 patients (59%), whereas using the DPP in only 10 subjects (25.6%). When associated, diagnostic evaluations detected 7 polyneuropaths (17.9%). There were no correlations between CIPNM diagnosis, time of MV, ICU or weaning.
Conclusions: The tools used in isolation or associated, to diagnose CIPNM identified the prevalence of weak patients. No correlations were identified between such weakness and longer time in MV, weaning time and prolonged ICU stay.
References
Carineu RFB, Cabral MM, Guimarães HP, Lopes RD, Saes LSV, Lopes AC. Polyneuropathy in the critical ill patient: a common diagnosis in intensive care medicine? Rev Bras Ter Intensiva. 2006;18(3): 307-10.
Zamora VEC, Cruz MR. Polineuropatia do paciente crítico: uma revisão da literatura. Revista HUPE. 2013;12(3):118-29.
Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.
Khan J, Harrison TB, Rich MM. Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin. 2008;24(1):165-x.
De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9): 2007-15.
Osler W. Principles and practice of medicine. New York: Appleton; 1892.
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47(11): 1223-31.
Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA. Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain. 1987;110(Pt 4):819-41.
Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy:
the electrophysiological components of a complex entity. Intensive Care Med. 2003;29(9):1505-14.
Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3): 261-8.
Garnacho-Montero J, Amaya Villar R, García-Garmendía JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005;33(2): 349-54.
van der Schaaf M, Beelen A, de Vos R. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil. 2004;26(20):1189-97.
Morris C, Trinder JT. Eletrophysiology adds little to clinical signs in critical illness polyneuropathy and myopathy. Crit Care Med. 2002;30(11):2612.
Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit: acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010;1(2):147-57.
Deem S, Lee CM, Curtis JR. Acquired neuromuscular disorders in the intensive care unit. Am J Respir Crit Care Med. 2003;168(7):735-9.
Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626-35.
Baldwin CE, Paratz JD, Bersten AD. Muscle strength assessment in critically ill patients with handheld dynamometry: an investigation of reliability, minimal detectable change, and time to peak force generation. J Crit Care. 2013;28(1):77-86.
Vanpee G, Segers J, Van Mechelen H, Wouters P, Van den Berghe G, Hermans G, et al. The interobserver agreement of handheld dynamometry for muscle strength assessment in critically ill patients. Crit Care Med. 2011;39(8):1929-34.
Hough CL, Lieu BK, Caldwell ES. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care. 2011;15(1):R43.
Fan E, Ciesla ND, Truong AD, Bhoopathi V, Zeger SL, Needham DM. Inter-rater reliability of manual muscle strength testing in ICU survivors and simulated patients. Intesive Care Med. 2010;36(6):1038-43.
Latronico N, Rasulo FA. Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care. 2010;16(2):123-7.
Hermans G, Clerckx B, Vanhullebusch T, Segers J, Vanpee G, Robbeets C, et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve. 2012;45(1):18-25.
Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74.
Cunningham C, Finlayson H. Critical illness polyneuromyopathy.
CMAJ. 2016;188(15):1104.
Baldwin MR, Reid MC, Westlake AA, Rowe JW, Granieri EC, Wunsch H, et al. The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors. J Crit Care. 2014;29(3):401-8.
Shepherd S, Batra A, Lerner DP. Review of critical illness myopathy and neuropathy. Neurohospitalist. 2017;7(1):41-8.
Via Clavero G, Sanjuán Naváis M, Menéndez Albuixech M, Corral Ansa L, Martínez Estalella G, Díaz-Prieto-Huidobro A. Evolution in muscle strength in critical patients with invasive mechanical ventilation. Enferm Intensiva. 2013;24(4):155-66
Parry SM, Berney S, Granger CL, Dunlop DL, Murphy L, El-Ansary D, et al. A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study. Crit Care. 2015;19(1):52.
Van Wagenberg L, Witteveen E, Wieske L, Horn J. Causes of mortality in ICU-acquired weakness. J Intensive Care Med. 2017 Jan 1:885066617745818. Epub ahead of print.
Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, Nollet F, Van Schaik IN, Schultz MJ, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196.
Sharshar T, Bastuji-Garin S, Stevens RD, Durand MC, Malissin I, Rodriguez P, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med. 2009;37(12):3047-53.
Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014; 190(4):410-20.
De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, DurandZaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22): 2859-67.
Downloads
Published
Issue
Section
License
COPYRIGHT
The submission of originals to Ciência & Saúde implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Ciência & Saúde as the site of original publication.
CREATIVE COMMONS LICENSE
As this journal is open access, the articles are allowed free use in scientific and educational applications, with citation of the source.
According to the type of Creative Commons License (CC-BY 4.0) adopted by Ciência & Saúde , the user must respect the requirements below.
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
However, only under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests Ciência & Saúde endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
For more details on the Creative Commons license, please follow the link in the footer of this website.
